Page last updated: 2024-09-05

ilaprazole and Epstein-Barr Virus Infections

ilaprazole has been researched along with Epstein-Barr Virus Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bhaduri-McIntosh, S; Bleck, CKE; Carter, C; Mannemuddhu, SS; Tjandra, N; Xu, H1

Other Studies

1 other study(ies) available for ilaprazole and Epstein-Barr Virus Infections

ArticleYear
Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency.
    Journal of virology, 2021, 06-10, Volume: 95, Issue:13

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; A549 Cells; Antiviral Agents; Cell Line, Tumor; DNA-Binding Proteins; Endosomal Sorting Complexes Required for Transport; Epstein-Barr Virus Infections; HEK293 Cells; Herpesvirus 4, Human; Humans; Proton Pump Inhibitors; Rabeprazole; Transcription Factors; Viral Load; Virus Activation; Virus Latency; Virus Release; Virus Replication

2021